PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cocktail aims to reboot immune attack on tough cancers
Disease control TerminatedThis early-phase study tested a drug called plinabulin combined with radiation and immunotherapy in 19 people with advanced cancers (like lung, bladder, or melanoma) that had stopped responding to standard immunotherapy. The goal was to see if the combo could shrink tumors or con…
Matched conditions: PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:05 UTC
-
Virus therapy shows promise for Hard-to-Treat melanoma
Disease control TerminatedThis early-stage trial tested a specially modified virus in 12 people with advanced melanoma that had spread or couldn't be removed. The virus was injected directly into tumors and into a vein, aiming to trigger the immune system to attack cancer cells. The main goals were to fin…
Matched conditions: PATHOLOGIC STAGE IIIA CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 15, 2026 18:54 UTC